http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0300900-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9160bb096a5c59c98f242f587e537811
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae5a2d015a95903dc395d0555dea97c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4317402186e691b7ba6c676842e63981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bcc0add13de6379981fac68693909ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b215606dc4be6808d6d43e656f23b5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d982592f350cf465d1c3ca2ec826fb1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f95563beadd4b638d13d63272cdeda6
publicationDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0300900-A2
titleOfInvention Polymorphs of N- [4- (3-chloro-4-fluorophenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride; and their use
abstract This invention relates to N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide of formula (I). polymorphic forms of the dihydrochloride are processes for their preparation and their use in the preparation of medicaments with irreversible tyrosine kinase inhibitors. SHE
priorityDate 2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450165613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156414

Total number of triples: 42.